Eric Schwartz I.'s Insider Trades & SAST Disclosures
Eric Schwartz I.'s most recent trade in Integra Lifesciences Holdings Corp was a trade of 1,538 Common Stock done at an average price of $23.9 . Disclosure was reported to the exchange on March 11, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Eric Schwartz I..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.95 per share. | 11 Mar 2025 | 1,538 | 57,200 (0%) | 0% | 23.9 | 36,835 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.95 per share. | 11 Mar 2025 | 1,180 | 56,020 (0%) | 0% | 24.0 | 28,261 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.61 per share. | 10 Mar 2025 | 773 | 58,738 (0%) | 0% | 22.6 | 17,478 | Common Stock |
| Integra Lifesciences Holdi... | Schwartz I. Eric | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 24.60 per share. | 03 Dec 2024 | 4,070 | 59,511 (0%) | 0% | 24.6 | 100,102 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 17,890 | 17,890 | - | - | Non- Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 8,283 | 65,019 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 7,745 | 56,736 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.22 per share. | 11 Mar 2024 | 1,371 | 48,991 (0%) | 0% | 36.2 | 49,658 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.88 per share. | 11 Mar 2024 | 1,090 | 63,929 (0%) | 0% | 35.9 | 39,109 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.88 per share. | 11 Mar 2024 | 348 | 63,581 (0%) | 0% | 35.9 | 12,486 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.73 per share. | 10 Mar 2024 | 799 | 50,362 (0%) | 0% | 36.7 | 29,347 | Common Stock |
| Integra Lifesciences Holdi... | Eric Schwartz I. | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 2,564 | 51,161 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Purchase of securities on an exchange or from another person at price $ 37.89 per share. | 01 Jun 2023 | 2,640 | 48,597 (0%) | 0% | 37.9 | 100,035 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 12,419 | 12,419 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 5,070 | 52,222 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 2,393 | 49,829 (0%) | 0% | 52.9 | 126,518 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 1,371 | 48,458 (0%) | 0% | 52.9 | 72,485 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.61 per share. | 10 Mar 2023 | 915 | 46,373 (0%) | 0% | 52.6 | 48,138 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 594 | 47,864 (0%) | 0% | 52.9 | 31,405 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.61 per share. | 10 Mar 2023 | 416 | 45,957 (0%) | 0% | 62.6 | 26,046 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 338 | 47,288 (0%) | 0% | 52.9 | 17,870 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 238 | 47,626 (0%) | 0% | 52.9 | 12,583 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 5,641 | 47,152 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 2,156 | 39,551 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 1,400 | 41,511 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 560 | 40,111 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Mar 2022 | 27,539 | 27,539 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 9,792 | 41,704 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 1,488 | 37,395 (0%) | 0% | 65.1 | 96,884 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 873 | 40,613 (0%) | 0% | 65.1 | 56,841 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 691 | 38,883 (0%) | 0% | 65.1 | 44,991 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 404 | 39,860 (0%) | 0% | 65.1 | 26,304 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 349 | 40,264 (0%) | 0% | 65.1 | 22,723 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 286 | 39,574 (0%) | 0% | 65.1 | 18,621 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 218 | 41,486 (0%) | 0% | 65.1 | 14,194 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.32 per share. | 01 Mar 2022 | 1,712 | 31,912 (0%) | 0% | 66.3 | 113,540 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 4,454 | 33,624 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 3,565 | 29,170 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 2,520 | 25,605 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.69 per share. | 03 Dec 2021 | 2,414 | 23,085 (0%) | 0% | 62.7 | 151,334 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 7,267 | 7,267 | - | - | Non- Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 2,411 | 25,939 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 261 | 25,499 (0%) | 0% | 68.1 | 17,774 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 179 | 25,760 (0%) | 0% | 68.1 | 12,190 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 69.10 per share. | 02 Mar 2021 | 4,212 | 23,528 (0%) | 0% | 69.1 | 291,031 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 69.52 per share. | 25 Feb 2021 | 2,288 | 29,409 (0%) | 0% | 69.5 | 159,062 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.43 per share. | 25 Feb 2021 | 1,669 | 27,740 (0%) | 0% | 69.4 | 115,879 | Common Stock |
| Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.92 per share. | 03 Dec 2020 | 1,515 | 31,697 (0%) | 0% | 54.9 | 83,204 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges